Atria Investments LLC Eli Lilly & CO Transaction History

Atria Investments LLC

$7.56 Billion
Q3 2024

A detailed history of Atria Investments LLC transactions in Eli Lilly & CO stock. As of the latest transaction made, Atria Investments LLC holds 45,993 shares of LLY stock, worth $36.6 Million. This represents 0.54% of its overall portfolio holdings.

Number of Shares

45,993

Previous 46,664 1.44%

Holding current value

$36.6 Million

Previous $42.2 Million 3.55%

% of portfolio

0.54%

Previous 0.57%

30 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 01, 2024	SELL	$772.14 - $960.02 $518,105 - $644,173	-671 Reduced 1.44%	45,993 $40.7 Million
Q2 2024 Aug 13, 2024	SELL	$724.87 - $909.04 $859,695 - $1.08 Million	-1,186 Reduced 2.48%	46,664 $42.2 Million
Q1 2024 May 21, 2024	BUY	$592.2 - $792.28 $3.35 Million - $4.48 Million	5,650 Added 13.39%	47,850 $37.2 Million
Q4 2023 Feb 14, 2024	BUY	$525.19 - $619.13 $1.77 Million - $2.09 Million	3,370 Added 8.68%	42,200 $24.6 Million
Q3 2023 Nov 07, 2023	BUY	$434.7 - $599.3 $129,975 - $179,190	299 Added 0.78%	38,830 $20.9 Million
Q2 2023 Aug 04, 2023	SELL	$350.74 - $468.98 $1.22 Million - $1.63 Million	-3,481 Reduced 8.29%	38,531 $18.1 Million
Q1 2023 May 10, 2023	SELL	$310.63 - $364.82 $746,443 - $876,662	-2,403 Reduced 5.41%	42,012 $14.4 Million
Q4 2022 Jan 31, 2023	BUY	$321.55 - $374.67 $243,413 - $283,625	757 Added 1.73%	44,415 $16.2 Million
Q3 2022 Nov 01, 2022	BUY	$296.48 - $337.87 $217,023 - $247,320	732 Added 1.71%	43,658 $14.1 Million
Q2 2022 Aug 11, 2022	BUY	$278.73 - $327.27 $1.44 Million - $1.69 Million	5,175 Added 13.71%	42,926 $13.9 Million
Q1 2022 May 02, 2022	BUY	$234.69 - $291.66 $971,381 - $1.21 Million	4,139 Added 12.31%	37,751 $10.8 Million
Q4 2021 Feb 04, 2022	SELL	$224.85 - $279.04 $250,482 - $310,850	-1,114 Reduced 3.21%	33,612 $9.28 Million
Q3 2021 Nov 16, 2021	BUY	$221.6 - $272.71 $198,996 - $244,893	898 Added 2.65%	34,726 $8.02 Million
Q2 2021 Aug 10, 2021	BUY	$180.55 - $233.54 $740,977 - $958,448	4,104 Added 13.81%	33,828 $7.76 Million
Q1 2021 May 11, 2021	SELL	$164.32 - $212.72 $2.02 Million - $2.62 Million	-12,315 Reduced 29.29%	29,724 $5.55 Million
Q4 2020 Feb 12, 2021	BUY	$130.46 - $172.63 $455,435 - $602,651	3,491 Added 9.06%	42,039 $7.1 Million
Q3 2020 Nov 05, 2020	SELL	$146.22 - $169.13 $3.83 Million - $4.43 Million	-26,210 Reduced 40.47%	38,548 $5.71 Million
Q2 2020 Sep 22, 2020	BUY	$136.42 - $164.18 $8.83 Million - $10.6 Million	64,758 New	64,758 $10.6 Million
Q1 2020 May 15, 2020	SELL	$119.05 - $147.35 $2.92 Million - $3.61 Million	-24,526 Closed	0 $0
Q4 2019 Feb 11, 2020	BUY	$106.92 - $132.43 $1.48 Million - $1.83 Million	13,854 Added 129.82%	24,526 $3.22 Million
Q3 2019 Nov 14, 2019	BUY	$106.79 - $116.16 $250,956 - $272,976	2,350 Added 28.24%	10,672 $1.19 Million
Q2 2019 Aug 26, 2019	SELL	$110.79 - $129.32 $1.93 Million - $2.25 Million	-17,419 Reduced 67.67%	8,322 $944,000
Q2 2019 Aug 09, 2019	BUY	$110.79 - $129.32 $1.94 Million - $2.27 Million	17,552 Added 214.34%	25,741 $108,000
Q1 2019 May 15, 2019	SELL	$111.31 - $131.02 $554,212 - $652,348	-4,979 Reduced 37.81%	8,189 $1.06 Million
Q4 2018 Feb 12, 2019	SELL	$105.9 - $118.64 $2.03 Million - $2.28 Million	-19,188 Reduced 59.3%	13,168 $1.52 Million
Q3 2018 Oct 09, 2018	SELL	$85.86 - $107.31 $678,895 - $848,500	-7,907 Reduced 19.64%	32,356 $3.47 Million
Q2 2018 Jul 13, 2018	SELL	$75.7 - $86.88 $516,501 - $592,782	-6,823 Reduced 14.49%	40,263 $3.44 Million
Q1 2018 Apr 30, 2018	BUY	$74.21 - $87.6 $2.4 Million - $2.83 Million	32,337 Added 219.25%	47,086 $3.64 Million
Q4 2017 Jan 16, 2018	SELL	$81.94 - $87.89 $2.44 Million - $2.62 Million	-29,835 Reduced 66.92%	14,749 $1.25 Million
Q3 2017 Oct 12, 2017	BUY	$77.07 - $85.54 $3.44 Million - $3.81 Million	44,584	44,584 $3.81 Million

Others Institutions Holding LLY

# of Institutions

4,011

Shares Held

751M

Call Options Held

8.27M

Put Options Held

10.5M

View Full List

About ELI LILLY & Co

Ticker LLY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 950,174,976
Market Cap $757B
Description
Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...

More about LLY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Atria Investments LLC, based on Form 13F filings with the SEC.

News

Stay updated on Atria Investments LLC with notifications on news.

Account

Atria Investments LLC Eli Lilly & CO Transaction History